SEC Filings :: Oncolytics Biotech, Inc. (ONCY)

Filing Type:

Year:

Date	Form	Description	Pages
05/26/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	4
05/26/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	5
05/11/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	4
05/10/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	4
05/05/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1 EX-99.2 EX-99.3 EX-99.4	33
05/05/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	10
04/26/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	4
04/12/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	3
04/12/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	3
04/12/23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents EX-99.1	4